Cargando…
Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group
PURPOSE: An aggressive trimodality approach from the Minnie Pearl Cancer Research Network [carboplatin AUC = 6, days 1 and 22; 5-fluorouracil 225 mg/m2 continuous infusion, days 1–42, paclitaxel 200 mg/m2, days 1 and 22; 45 Gy] has resulted in remarkable pathologic response rates but notable toxicit...
Autores principales: | Jatoi, Aminah, Martenson, James, Mahoney, Michelle R, Lair, Bradley S, Brindle, Jeffrey S, Nichols, Frank, Caron, Normand, Rowland, Kendrith, Tschetter, Loren, Alberts, Steven |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529465/ https://www.ncbi.nlm.nih.gov/pubmed/15533252 http://dx.doi.org/10.1186/1477-7800-1-9 |
Ejemplares similares
-
Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E
por: Katipamula, Rajini, et al.
Publicado: (2008) -
Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice.
por: Korst, A. E., et al.
Publicado: (1997) -
Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222
por: Jatoi, Aminah, et al.
Publicado: (2009) -
AUC of Calvert's formula in targeted intra-arterial carboplatin chemoradiotherapy for cancer of the oral cavity
por: Oya, R, et al.
Publicado: (2004) -
Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation
por: Barbosa, S.C.M., et al.
Publicado: (2019)